sibutramine has been researched along with Aortic Valve Insufficiency in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Aortic Valve Insufficiency: Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obese patients with type 2 diabetes mellitus enrolled in an ongoing double-blind, placebo-controlled, parallel-arm, 12-month study of sibutramine (followed by a 12-month open label extension) underwent transthoracic echocardiographic imaging and color Doppler interrogation for assessment of cardiac valve anatomy and function." | 2.69 | Absence of cardiac valve dysfunction in obese patients treated with sibutramine. ( Armstrong, WF; Bach, DS; Kelly, F; Mendel, CM; Patel, B; Pekkarinen, TA; Rissanen, AM; Seaton, TB; Shepherd, G; Weinstein, SP, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, DS | 1 |
| Rissanen, AM | 1 |
| Mendel, CM | 1 |
| Shepherd, G | 1 |
| Weinstein, SP | 1 |
| Kelly, F | 1 |
| Seaton, TB | 1 |
| Patel, B | 1 |
| Pekkarinen, TA | 1 |
| Armstrong, WF | 1 |
1 trial available for sibutramine and Aortic Valve Insufficiency
| Article | Year |
|---|---|
Absence of cardiac valve dysfunction in obese patients treated with sibutramine.
Topics: Adult; Aged; Aortic Valve Insufficiency; Appetite Depressants; Body Mass Index; Cyclobutanes; Diabet | 1999 |